Maravai Lifesciences Holdings Inc Cl A (MRVI)

$2.01 -0.04 (-1.95%)
Market Cap 493.41M
Revenue (ttm) 259.19M
Net Income (ttm) -144.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -55.89%
Debt to Equity Ratio 0.51
Volume 617,977
Avg Vol 3,699,226
Day's Range N/A - N/A
Shares Out 254.34M
Stochastic %K 70%
Beta 0.18
Analysts Sell
Price Target $5.89

Latest News on MRVI

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Apr 19, 2025, 7:36 AM EDT - 9 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations – Hagens Berman

Apr 16, 2025, 6:10 PM EDT - 11 days ago

Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations – Hagens Berman

Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations - Hagens Berman

Apr 15, 2025, 6:00 PM EDT - 12 days ago

Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations - Hagens Berman

MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI

Apr 15, 2025, 9:35 AM EDT - 13 days ago

MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Apr 9, 2025, 11:23 AM EDT - 19 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2024 Earnings Conference Call Transcript

Mar 20, 2025, 9:00 PM EDT - 5 weeks ago

Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2024 Earnings Conference Call Transcript

Time-Sensitive: Maravai Lifesciences (MRVI) Investors May Have Legal Claims - Act Before May 5 Deadline

Mar 20, 2025, 11:45 AM EDT - 5 weeks ago

Time-Sensitive: Maravai Lifesciences (MRVI) Investors May Have Legal Claims - Act Before May 5 Deadline

Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 18, 2025, 4:05 PM EDT - 5 weeks ago

Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results

Cohen Milstein Alerts Maravai LifeSciences Investors To Potential Securities Fraud Claims

Mar 17, 2025, 12:45 PM EDT - 6 weeks ago

Cohen Milstein Alerts Maravai LifeSciences Investors To Potential Securities Fraud Claims

Cohen Milstein Encourages Shareholders Who Lost Money In Maravai Lifesciences Holdings, Inc. (MRVI) To Contact The Firm

Mar 12, 2025, 11:00 AM EDT - 6 weeks ago

Cohen Milstein Encourages Shareholders Who Lost Money In Maravai Lifesciences Holdings, Inc. (MRVI) To Contact The Firm

Cohen Milstein Urges Shareholders Who Lost Significant Money in Maravai LifeSciences Holdings, Inc. (MRVI) to Contact Firm

Mar 6, 2025, 3:30 PM EST - 7 weeks ago

Cohen Milstein Urges Shareholders Who Lost Significant Money in Maravai LifeSciences Holdings, Inc. (MRVI) to Contact Firm

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation

Mar 5, 2025, 10:00 AM EST - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation

MRVI LAWSUIT: Maravai LifeSciences Holdings Inc. Sued For Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losses

Mar 4, 2025, 2:50 PM EST - 7 weeks ago

MRVI LAWSUIT: Maravai LifeSciences Holdings Inc. Sued For Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losses

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out

Mar 4, 2025, 10:00 AM EST - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out

MRVI INVESTIGATION: Robbins Geller Rudman & Dowd LLP Announces Investigation into Maravai LifeSciences Holdings, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Mar 4, 2025, 6:15 AM EST - 7 weeks ago

MRVI INVESTIGATION: Robbins Geller Rudman & Dowd LLP Announces Investigation into Maravai LifeSciences Holdings, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out

Mar 3, 2025, 5:00 PM EST - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out

Maravai LifeSciences Holdings, Inc. (MRVI) Shares Fall 21% After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition – Hagens Berman

Mar 3, 2025, 3:46 PM EST - 7 weeks ago

Maravai LifeSciences Holdings, Inc. (MRVI) Shares Fall 21% After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition – Hagens Berman

MRVI INVESTIGATION NOTICE: Investigation Launched into Maravai LifeSciences Holdings, Inc. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm

Mar 1, 2025, 12:05 AM EST - 2 months ago

MRVI INVESTIGATION NOTICE: Investigation Launched into Maravai LifeSciences Holdings, Inc. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm

Maravai LifeSciences Holdings, Inc. (MRVI) Shares Fall 21% After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition - Hagens Berman

Feb 28, 2025, 9:31 AM EST - 2 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Shares Fall 21% After Delaying Q4 and FY 2024 Earnings Release, Admitting to Improper Revenue Recognition - Hagens Berman